標(biāo)題: Titlebook: Hypertrophic Cardiomyopathy; Srihari S. Naidu Book 2019Latest edition Springer International Publishing AG, part of Springer Nature 2019 A [打印本頁(yè)] 作者: 抵押證書(shū) 時(shí)間: 2025-3-21 18:11
書(shū)目名稱Hypertrophic Cardiomyopathy影響因子(影響力)
作者: 金絲雀 時(shí)間: 2025-3-21 21:00
Vertrieb 2.0: Die Zukunft im Blick,catheterization in the 1960s, many more patients with HCM were identified, and its unique pathophysiology was described. At present, echocardiography is employed almost universally in diagnosis, while therapy involves the use of several drugs, interventions to relieve obstruction as well as the impl作者: LOPE 時(shí)間: 2025-3-22 01:37 作者: 詼諧 時(shí)間: 2025-3-22 05:34
https://doi.org/10.1007/978-3-642-77738-7s, and function, which have diagnostic, as well as prognostic value. Magnetic resonance tagging and delayed enhancement with gadolinium contrast agents allow for strain and perfusion analysis, further increasing the utility of CMR to detect regional function and cardiac microvascular ischemia. Delay作者: 武器 時(shí)間: 2025-3-22 11:02 作者: 擋泥板 時(shí)間: 2025-3-22 14:30 作者: obscurity 時(shí)間: 2025-3-22 20:55 作者: 軌道 時(shí)間: 2025-3-22 21:24
https://doi.org/10.1007/978-3-662-54769-4 activities, and this may have implications on patient employment. However, strict exercise proscriptions are not warranted, and in most cases moderate exercise should be encouraged as a component of a healthy lifestyle. As with nearly all aspects of HCM patient care, recommendations about lifestyle作者: 細(xì)查 時(shí)間: 2025-3-23 03:08 作者: 散步 時(shí)間: 2025-3-23 07:23
https://doi.org/10.1007/978-3-658-01392-9 discusses the management of apical hypertrophic cardiomyopathy, hypertrophic cardiomyopathy associated with mid-ventricular obstruction, transformation into LV systolic dysfunction, and takotsubo cardiomyopathy in patients with HCM.作者: Terrace 時(shí)間: 2025-3-23 13:29 作者: 針葉樹(shù) 時(shí)間: 2025-3-23 17:32 作者: AXIS 時(shí)間: 2025-3-23 18:58
Book 2019Latest editionapy (both surgical myectomy and alcohol septal ablation) – in addition to genetics, family screening, lifestyle concerns, and athletic screening. The practical approach has been reinforced with an expanded emphasis on creating a Center of Excellence, how to facilitate the multi-disciplinary approach作者: Tempor 時(shí)間: 2025-3-24 00:48 作者: Camouflage 時(shí)間: 2025-3-24 03:35
Pathology and Pathophysiology,dial ischemia, and arrhythmia. Sudden death is not an uncommon complication of HCM and is often precipitated by exercise. The frequency of sudden death in HCM is up to 1% per year in adults with 2–4% per year in children and adolescents.作者: A簡(jiǎn)潔的 時(shí)間: 2025-3-24 10:29
Cardiac MRI in Diagnosis and Management,s, and function, which have diagnostic, as well as prognostic value. Magnetic resonance tagging and delayed enhancement with gadolinium contrast agents allow for strain and perfusion analysis, further increasing the utility of CMR to detect regional function and cardiac microvascular ischemia. Delay作者: Astigmatism 時(shí)間: 2025-3-24 10:56
Assessment of Heart Failure: Invasive and Noninvasive Methods,resent, and excluding other pathologic causes of left ventricular thickening. Cardiopulmonary exercise testing provides quantification of functional capacity and distinguishes between cardiac and pulmonary contributions to symptoms.作者: dandruff 時(shí)間: 2025-3-24 18:23 作者: 舊石器時(shí)代 時(shí)間: 2025-3-24 20:41
Youth and Athletic Screening: Rationale, Methods, and Outcome,ll cohorts of young people under the conditions of sufficient provider expertise and quality control. However, barriers to widespread use of ECG screening remain, including concerns about ethics, logistics, cost-effectiveness, and overall health outcomes.作者: 大喘氣 時(shí)間: 2025-3-25 02:49
Lifestyle Modification: Diet, Exercise, Sports, and Other Issues, activities, and this may have implications on patient employment. However, strict exercise proscriptions are not warranted, and in most cases moderate exercise should be encouraged as a component of a healthy lifestyle. As with nearly all aspects of HCM patient care, recommendations about lifestyle作者: explicit 時(shí)間: 2025-3-25 06:03 作者: 極微小 時(shí)間: 2025-3-25 10:13 作者: 蛙鳴聲 時(shí)間: 2025-3-25 12:13 作者: grotto 時(shí)間: 2025-3-25 18:28
Epicardial and Microvascular Ischemia: Implications, Diagnosis, and Management, of diastolic suction secondary to impaired diastolic relaxation. Repetitive ischemic insults leads to myocardial injury and subsequent myocardial fibrosis. Myocardial ischemia in HCM patients is associated with increased mortality, ventricular tachycardia, left ventricular remodeling and dysfunctio作者: 增長(zhǎng) 時(shí)間: 2025-3-25 22:53 作者: nascent 時(shí)間: 2025-3-26 03:10
https://doi.org/10.1007/978-981-16-8961-1 these patients: arrhythmogenic causes (bradycardia and tachycardia), left ventricular outflow tract obstruction, and neurocardiogenic causes. An approach to the evaluation of the syncope in terms of etiology, diagnosis, and recommended treatment is presented.作者: 花爭(zhēng)吵 時(shí)間: 2025-3-26 04:43
Correlation and Gene Co-Expression Networks,clinical parameters. Other clinical features, such as myocardial fibrosis, LV apical aneurysms and multiple sarcomere protein gene mutations, are also used to guide ICD therapy. Prevention of sudden death relies on lifestyle modification and ICD therapy.作者: Offstage 時(shí)間: 2025-3-26 09:01
Assessment of Syncope, these patients: arrhythmogenic causes (bradycardia and tachycardia), left ventricular outflow tract obstruction, and neurocardiogenic causes. An approach to the evaluation of the syncope in terms of etiology, diagnosis, and recommended treatment is presented.作者: 場(chǎng)所 時(shí)間: 2025-3-26 12:38
Sudden Cardiac Death Risk Assessment,clinical parameters. Other clinical features, such as myocardial fibrosis, LV apical aneurysms and multiple sarcomere protein gene mutations, are also used to guide ICD therapy. Prevention of sudden death relies on lifestyle modification and ICD therapy.作者: 鄙視 時(shí)間: 2025-3-26 18:23
Springer International Publishing AG, part of Springer Nature 2019作者: 過(guò)剩 時(shí)間: 2025-3-26 22:33 作者: 共同生活 時(shí)間: 2025-3-27 01:25
http://image.papertrans.cn/h/image/430742.jpg作者: fastness 時(shí)間: 2025-3-27 07:01
Peter M. Schlag,J?rg T. Hartmannlation, or stroke. The presence of left ventricular outflow tract obstruction, development of systolic dysfunction (i.e., end-stage HCM), and possibly apical aneurysms has been associated with worse outcomes.作者: NIP 時(shí)間: 2025-3-27 10:45
Das Syndrom der oberen Thoraxapertur,raphy offers the clinician a comprehensive imaging modality in those with suspected HCM, as well as those already diagnosed and those undergoing surveillance or therapeutic intervention. In this chapter, we detail the benefits of echocardiography for the diagnosis, monitoring, and management of those with suspected or known HCM.作者: zonules 時(shí)間: 2025-3-27 15:11 作者: hermitage 時(shí)間: 2025-3-27 18:38 作者: Blanch 時(shí)間: 2025-3-27 23:37
Natural History of Hypertrophic Cardiomyopathy,lation, or stroke. The presence of left ventricular outflow tract obstruction, development of systolic dysfunction (i.e., end-stage HCM), and possibly apical aneurysms has been associated with worse outcomes.作者: Blood-Vessels 時(shí)間: 2025-3-28 02:22
Approach to Diagnosis: Echocardiography,raphy offers the clinician a comprehensive imaging modality in those with suspected HCM, as well as those already diagnosed and those undergoing surveillance or therapeutic intervention. In this chapter, we detail the benefits of echocardiography for the diagnosis, monitoring, and management of those with suspected or known HCM.作者: 特征 時(shí)間: 2025-3-28 09:00 作者: HACK 時(shí)間: 2025-3-28 12:08 作者: Limpid 時(shí)間: 2025-3-28 17:02 作者: EVEN 時(shí)間: 2025-3-28 21:40
Genetics of HCM and Role of Genetic Testing,pplication of the genetic result in the setting of the HCM family are all key components of care. The latest genetic technologies, including whole genome sequencing, will likely translate to a greater understanding of the genetic and molecular underpinnings of HCM.作者: Antimicrobial 時(shí)間: 2025-3-28 23:38 作者: 冥想后 時(shí)間: 2025-3-29 06:52
Gitta Günther,Wolfram Huschke,Walter Steinery function as biomarkers in demonstrating treatment responses, that bleeding is as prevalent as in aortic stenosis, and that septal reduction therapy can be curative of transfusion-dependent gastrointestinal hemorrhage from angiodysplasia.作者: Lice692 時(shí)間: 2025-3-29 10:43 作者: LVAD360 時(shí)間: 2025-3-29 12:47
ntrates on the multi-disciplinary and longitudinal nature of.This extensively updated edition provides a comprehensive review of hypertrophic cardiomyopathy, the most common genetic disorder of the heart characterized by dysfunctional contractility at the sarcomere level. The disease produces abnorm作者: 托人看管 時(shí)間: 2025-3-29 19:21 作者: 商店街 時(shí)間: 2025-3-29 21:24
Peter M. Schlag,J?rg T. Hartmannly adulthood. Mortality rates in HCM are lower than initially suspected, especially in treated patients, but remain higher than those in the general population. Although the majority of HCM patients develop few or no symptoms, a significant minority will develop advanced heart failure, atrial fibril作者: 凹處 時(shí)間: 2025-3-30 03:15
C. F. Claussen,B. Kaute,D. Schneiderrse clinical course. Clinically HCM requires a hypertrophied non-dilated left ventricle without evidence of any other cardiac or systemic disease that could produce the extent of hypertrophy observed. In the vast majority of individual adults dying from HCM, there is cardiomegaly typically in the ra作者: conscience 時(shí)間: 2025-3-30 05:43 作者: Corporeal 時(shí)間: 2025-3-30 09:16 作者: Nebulous 時(shí)間: 2025-3-30 16:04 作者: Clumsy 時(shí)間: 2025-3-30 17:27
Psychological aspects of obesity,t (“forward” heart failure). The mainstay of noninvasive testing in symptomatic patients with HCM is transthoracic echocardiography. The detection of concomitant coronary artery disease (CAD) as a cause of symptoms may be difficult by clinical assessment and exercise testing; cardiac computerized to作者: V切開(kāi) 時(shí)間: 2025-3-30 22:41 作者: 獸皮 時(shí)間: 2025-3-31 03:12
https://doi.org/10.1007/978-90-481-8957-1d to this disease in adults. Management and diagnosis in infants and young children in particular are associated with unique considerations. Etiology is an important determinant of survival, particularly in the youngest patients, and pursuit of a specific cause is therefore requisite. Diagnosis is m作者: Abominate 時(shí)間: 2025-3-31 06:12 作者: 藝術(shù) 時(shí)間: 2025-3-31 10:56 作者: 殺子女者 時(shí)間: 2025-3-31 16:03 作者: 雀斑 時(shí)間: 2025-3-31 20:17
,Weihrauch (Olibanum) – was ist das?,on to other chronic cardiac conditions, such as heart failure with reduced ejection fraction or following myocardial infarction, there is a distinct paucity of high-quality clinical trial data to inform decision-making, and current guidelines avoid making any specific recommendations in much of the 作者: Palate 時(shí)間: 2025-4-1 01:12
https://doi.org/10.1007/978-3-658-01390-5on. The goals of family screening are to identify relatives with unrecognized HCM and to follow at-risk individuals for risk factors of SCD and disease development..After confirmation of the HCM diagnosis, the patient is informed about the familial character of the disease, the high potential for fa作者: 懶洋洋 時(shí)間: 2025-4-1 03:05
https://doi.org/10.1007/978-3-658-01392-9patient. Many patients can be managed conservatively with few or even no medications. The history, physical examination, and baseline echocardiogram usually determine the need for, type of, and titration of medications. Obstructive and nonobstructive patients are treated differently. Medications sho作者: duplicate 時(shí)間: 2025-4-1 09:25 作者: 通知 時(shí)間: 2025-4-1 12:11
